{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:59:45Z","timestamp":1772780385226,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T00:00:00Z","timestamp":1485475200000},"content-version":"am","delay-in-days":332,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81273526"],"award-info":[{"award-number":["81273526"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81473268"],"award-info":[{"award-number":["81473268"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["1308085MH145"],"award-info":[{"award-number":["1308085MH145"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anhui Science and Technology Research Projects","award":["1301042212"],"award-info":[{"award-number":["1301042212"]}]},{"name":"Specialized Research Fund for the Doctoral Program of Higher Education of China","award":["20123420120001"],"award-info":[{"award-number":["20123420120001"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.taap.2016.01.012","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T22:30:40Z","timestamp":1453415440000},"page":"43-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Role of NLRC5 in progression and reversal of hepatic fibrosis"],"prefix":"10.1016","volume":"294","author":[{"given":"Xuejiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2016.01.012_bb0005","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jri.2010.12.003","article-title":"The role of the nod-like receptor family in trophoblast innate immune responses","volume":"88","author":"Abrahams","year":"2011","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.taap.2016.01.012_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2016.01.012_bb0015","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.4049\/jimmunol.0903900","article-title":"NLRC5 limits the activation of inflammatory pathways","volume":"185","author":"Benko","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2016.01.012_bb0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jhep.2014.09.032","article-title":"CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt","volume":"62","author":"Berres","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2016.01.012_bb0025","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cell.2010.03.040","article-title":"NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways","volume":"141","author":"Cui","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.taap.2016.01.012_bb0030","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.taap.2016.01.012_bb0035","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4049\/jimmunol.1003111","article-title":"Cutting edge: NLRC5-dependent activation of the inflammasome","volume":"186","author":"Davis","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2016.01.012_bb0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","article-title":"TGF-beta in progression of liver disease","volume":"347","author":"Dooley","year":"2012","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.taap.2016.01.012_bb0045","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1136\/gutjnl-2013-306294","article-title":"CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis","volume":"63","author":"Ehling","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.taap.2016.01.012_bb0050","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jhep.2011.09.024","article-title":"Clinical evidence for the regression of liver fibrosis","volume":"56","author":"Ellis","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2016.01.012_bb0055","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"Friedman","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2016.01.012_bb0060","doi-asserted-by":"crossref","first-page":"9230","DOI":"10.1073\/pnas.1206645109","article-title":"Fibrogenic cell reversion underlies fibrosis regression in liver","volume":"109","author":"Friedman","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2016.01.012_bb0065","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/hep.20974","article-title":"Reversal of hepatic fibrosis \u2013 fact or fantasy?","volume":"43","author":"Friedman","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2016.01.012_bb0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrd2783","article-title":"Unleashing the therapeutic potential of NOD-like receptors","volume":"8","author":"Geddes","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2016.01.012_bb0075","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.taap.2016.01.012_bb0080","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2012.02.004","article-title":"Recent developments in myofibroblast biology: paradigms for connective tissue remodeling","volume":"180","author":"Hinz","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.taap.2016.01.012_bb0085","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.23226","article-title":"Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection","volume":"50","author":"Hosel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2016.01.012_bb0090","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors","volume":"102","author":"Iredale","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2016.01.012_bb0095","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.immuni.2007.10.002","article-title":"Intracellular NOD-like receptors in host defense and disease","volume":"27","author":"Kanneganti","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.taap.2016.01.012_bb0100","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/hep.22701","article-title":"p75 neurotrophin receptor signaling regulates hepatic myofibroblast proliferation and apoptosis in recovery from rodent liver fibrosis","volume":"49","author":"Kendall","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2016.01.012_bb0105","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-0030-1253227","article-title":"The role of inflammation in cholestasis: clinical and basic aspects","volume":"30","author":"Kosters","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.taap.2016.01.012_bb0110","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","article-title":"Senescence of activated stellate cells limits liver fibrosis","volume":"134","author":"Krizhanovsky","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.taap.2016.01.012_bb0115","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.4049\/jimmunol.0900557","article-title":"The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses","volume":"184","author":"Kuenzel","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2016.01.012_bb0120","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/CCO.0000000000000042","article-title":"Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer","volume":"26","author":"Lade","year":"2014","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.taap.2016.01.012_bb0125","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10753-013-9804-y","article-title":"NLRC5 mediates cytokine secretion in RAW264.7 macrophages and modulated by the JAK2\/STAT3 pathway","volume":"37","author":"Li","year":"2014","journal-title":"Inflammation"},{"key":"10.1016\/j.taap.2016.01.012_bb0130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-kappaB in the liver\u2013linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2016.01.012_bb0135","doi-asserted-by":"crossref","first-page":"C789","DOI":"10.1152\/ajpcell.00230.2013","article-title":"Cellular mechanisms of tissue fibrosis. 5. novel insights into liver fibrosis. American journal of physiology","volume":"305","author":"Mallat","year":"2013","journal-title":"Cell. Physiol."},{"key":"10.1016\/j.taap.2016.01.012_bb0140","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jhep.2009.03.007","article-title":"Signalling pathways in alcohol-induced liver inflammation","volume":"50","author":"Mandrekar","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2016.01.012_bb0145","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2016.01.012_bb0150","doi-asserted-by":"crossref","first-page":"13794","DOI":"10.1073\/pnas.1008684107","article-title":"NLR family member NLRC5 is a transcriptional regulator of MHC class I genes","volume":"107","author":"Meissner","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2016.01.012_bb0155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature04946","article-title":"Intracellular pattern recognition receptors in the host response","volume":"442","author":"Meylan","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.taap.2016.01.012_bb0160","doi-asserted-by":"crossref","first-page":"26223","DOI":"10.1074\/jbc.M110.109736","article-title":"A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses","volume":"285","author":"Neerincx","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2016.01.012_bb0165","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1089\/ars.2013.5619","article-title":"Role of NADPH oxidases in liver fibrosis","volume":"20","author":"Paik","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.taap.2016.01.012_bb0170","doi-asserted-by":"crossref","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","article-title":"Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation","volume":"290","author":"Reddy","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.taap.2016.01.012_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137875","article-title":"Differential relevance of NF-kappaB and JNK in the pathophysiology of hemorrhage\/resususcitation-induced liver injury after chronic ethanol feeding","volume":"10","author":"Relja","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2016.01.012_bb0180","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1096\/fj.05-4828com","article-title":"Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice","volume":"20","author":"Roderfeld","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2016.01.012_bb0185","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.yexmp.2011.11.005","article-title":"Hop bitter acids exhibit anti-fibrogenic effects on hepatic stellate cells in vitro","volume":"92","author":"Saugspier","year":"2012","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.taap.2016.01.012_bb0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tem.2015.01.002","article-title":"Adipocytokines and hepatic fibrosis","volume":"26","author":"Saxena","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.taap.2016.01.012_bb0195","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1074\/jbc.M410078200","article-title":"Adipogenic transcriptional regulation of hepatic stellate cells","volume":"280","author":"She","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2016.01.012_bb0200","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.4049\/jimmunol.1102671","article-title":"NLRC5 deficiency selectively impairs MHC class I- dependent lymphocyte killing by cytotoxic T cells","volume":"188","author":"Staehli","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2016.01.012_bb0205","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/cr.2012.53","article-title":"Enhanced TLR-induced NF-kappaB signaling and type I interferon responses in NLRC5 deficient mice","volume":"22","author":"Tong","year":"2012","journal-title":"Cell Res."},{"key":"10.1016\/j.taap.2016.01.012_bb0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/0-387-24180-9_5","article-title":"NF-kappaB, an evolutionarily conserved mediator of immune and inflammatory responses","volume":"560","author":"Xiao","year":"2005","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.taap.2016.01.012_bb0215","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.taap.2016.01.012_bb0220","first-page":"92","article-title":"NLRC5 mediates IL-6 and IL-1beta secretion in LX-2 cells and modulated by the NF-kappaB\/Smad3 pathway","volume":"70","author":"Xu","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.taap.2016.01.012_bb0225","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s13238-012-2109-3","article-title":"Expression regulation and function of NLRC5","volume":"4","author":"Yao","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.taap.2016.01.012_bb0230","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/cr.2012.56","article-title":"NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens","volume":"22","author":"Yao","year":"2012","journal-title":"Cell Res."},{"key":"10.1016\/j.taap.2016.01.012_bb0235","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/pmic.201300539","article-title":"SILAC-based quantitative proteomic analysis of secretome between activated and reverted hepatic stellate cells","volume":"14","author":"Zhang","year":"2014","journal-title":"Proteomics"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X1630014X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X1630014X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:44:16Z","timestamp":1758573856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X1630014X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":47,"alternative-id":["S0041008X1630014X"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2016.01.012","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of NLRC5 in progression and reversal of hepatic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2016.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}